NCT05351957

Brief Summary

The aim of the study is to evaluate the efficacy of dry needling (DN) in the treatment of spasticity in patients with multiple sclerosis (MS). \[Participants and Methods\] participants with MS, with no evidence of a relapse in the last four weeks and with an EDSS (Expanded Disability Sta- tus Scale) greater than 2.5 points (related with pyramidal score) were recruited. DN was performed in lower limbs for 12 consecutive sessions and evaluated with: EDSS (Pyramidal item), Time up and go (TUG), 25 foot, 9hold peg test (9HPT) and the improvement or not in the quality of life (MSQol54) was verified before and after treatment. A follow up visit was carried out to assess improvement.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable multiple-sclerosis

Timeline
Completed

Started Feb 2018

Typical duration for not_applicable multiple-sclerosis

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 18, 2018

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 20, 2020

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 22, 2020

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

April 21, 2022

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 28, 2022

Completed
Last Updated

April 28, 2022

Status Verified

April 1, 2022

Enrollment Period

2.2 years

First QC Date

April 21, 2022

Last Update Submit

April 27, 2022

Conditions

Keywords

Dry needling, multiple sclerosis, physiotherapy

Outcome Measures

Primary Outcomes (5)

  • Change in 9HOLD PEG TEST score

    This consists of placing the pegs in the corresponding holes of the 9 holes in the table in the shortest possible time (seconds)

    inmediatly before and inmediatly after intervention

  • Change in 25 foot walk score

    patients must walk a distance of 7.25 meters at the fastest and safest speed for them (seconds)

    inmediatly before and inmediatly after intervention

  • Change in Time up and go test score

    The participants sit in a chair with their backs supported by the back of the chair and their arms resting on the armrests. The participants are asked to get up from the chair and walk a distance of 3 meters, then the patients turn on themselves (360°), walk back to the chair and sit down again (seconds)

    inmediatly before and inmediatly after intervention

  • Change in Expanded Disability Status Scale (EDSS) score

    Each item is valued individually and a score is given, which will then outline the patient's total EDSS ranging from 0 to 10, for use in the exploration sessions. All scans were carried out by a blind explorer.

    inmediatly before and inmediatly after intervention

  • Change in Multiple sclerosis Quality of life-54 (MSQol54) score

    questionnaire of 54 items measuring the quality of life of the patient. It can be self-administered or hetero-administered and both physical and mental aspects are measured. Within these there are subscales: among them quality of life in general. Two summary scores, physical health and mental health, can be derived from a weighted combination of scale scores. They range from 0 to 100, where 100 is the highest quality of life (both for physical and mental health)

    inmediatly before and inmediatly after intervention

Study Arms (1)

dry needling

EXPERIMENTAL

This study has only 1 arm and the control group is their baseline data

Procedure: Dry needling

Interventions

Dry needlingPROCEDURE

Only dry needling of the lower limbs will performed in all patients with acupunture needling

dry needling

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Being a patient diagnosed with multiple sclerosis.
  • Being over 18 years of age and less than or equal to 60 years of age.
  • Having a score equal to or greater than 2 in the EDSS.
  • They need to have a measurement in the following functional systems: P (pyramidal) \>2, CT (brainstem), gait \>2 and sphincter \>2.
  • They need to present hypertonia or contractures of the muscles selected for the dry needling, the pain expressed by the patients must be a consequence of spastic processes, have hourly availability to receive therapies and not have needle phobias.

You may not qualify if:

  • Having a disease associated with multiple sclerosis that is incompatible with dry needling.
  • Being in relapse, or having suffered it in the thirty days prior to starting the treatment. program or taking medications that are contraindicated with the technique applied in the study, (oral anticoagulants.)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Universitario de Canarias

San Cristóbal de La Laguna, Santa Cruz De Tenerife, 38320, Spain

Location

MeSH Terms

Conditions

Multiple Sclerosis

Interventions

Dry Needling

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System Diseases

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeuticsPhysical Therapy Modalities

Study Officials

  • MONSERRAT GONZÁLEZ-PLATAS

    Hospital Universitario de Canarias

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Physiotherapist

Study Record Dates

First Submitted

April 21, 2022

First Posted

April 28, 2022

Study Start

February 18, 2018

Primary Completion

April 20, 2020

Study Completion

September 22, 2020

Last Updated

April 28, 2022

Record last verified: 2022-04

Data Sharing

IPD Sharing
Will not share

Locations